RecruitingNot Applicable

Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease

United States600 participantsStarted 2026-03-10

Plain-language summary

Through the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients with advanced chronic kidney disease (CKD). The overall project goals are to 1.) Design and conduct community-engaged clinical trials to test new interventions that dismantle the systemic factors that contribute to kidney health disparities. 2.) Foster research collaborations between investigators, people living with kidney disease, community-based organizations, and other key stakeholders. Researchers aim to assess whether the KHC intervention is effective at delaying the transition to kidney replacement therapy (KRT) and central venous catheter use or death.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Identifies as African American or Black * Two estimated glomerular filtration rates (eGFRs) \< 29 separated by at least 90 days but within the past 2 years or a Kidney Failure Risk Equation (KFRE) score of 10% or greater likelihood of kidney failure within the next 2 years * Had an encounter at Emory University Hospital-Midtown through an ambulatory visit or inpatient stay (i.e., ER or hospital visit within the previous 2 months * Stated willingness to comply with all study procedures and availability for the duration of the study Exclusion Criteria: * Currently on dialysis * currently receiving hospice care or other types of conservative management for terminal illness * Currently on waitlist, or referred for/or completed a transplant evaluation visit within the past 2 years * Kidney or another solid organ transplant * Active cancer treatment * Non-English speaking * Participating in another treatment or intervention study at the time of enrollment * Currently pregnant or planning to become pregnant at the time of recruitment

What they're measuring

Time-to-Kidney Replacement Therapy w/Central Venous Catheter

Timeframe: Throughout study participation up to 12 months

Time-to-death

Timeframe: Throughout study participation up to 12 months

Trial details

NCT IDNCT06693661

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-03

Contact for this trial

Kimberly R Jacob Arriola, PhD, MPH

404-727-2600 kjacoba@emory.edu